Literature DB >> 11588545

Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans.

M A Eloubeidi1, D Provenzale.   

Abstract

BACKGROUND: The subgroup of patients with gastroesophageal reflux disease (GERD) that should undergo endoscopy to rule out Barrett's esophagus (BE) has not been well defined. GOALS: To examine demographic and clinical variables predictive of BE before endoscopy. STUDY: A validated GERD questionnaire was administered to 107 patients with biopsy-proven BE and to 104 patients with GERD but no BE shown by endoscopy. Frequent symptoms were defined as symptoms that occurred at least once or more each week. Severity of symptoms was rated on a scale from 1 to 4 (mild to very severe). Univariate analysis and multivariable logistic regression were performed to determine whether demographic characteristics and the duration, severity, and frequency of GERD symptoms were associated with the identification of BE.
RESULTS: Eighty-five percent of the GERD patients and 82% of the BE patients completed the questionnaire. There was no difference between the groups in terms of race, gender, or proton pump inhibitor use. The BE patients were older (median age, 64 vs. 57 years, p = 0.04). In multivariable logistic regression, an age of more than 40 years ( p = 0.008), the presence of heartburn or acid regurgitation ( p = 0.03), and heartburn more than once a week ( p = 0.007) were all independent predictors of the presence of BE. Interestingly, patients with BE were less likely to report severe GERD symptoms ( p = 0.0008) and nocturnal symptoms ( p = 0.03). Duration of symptoms, race, alcohol, and smoking history were not associated with BE.
CONCLUSIONS: Upper endoscopy should be performed in GERD patients more than 40 years of age who report heartburn once or more per week. The severity of symptoms and the presence of nocturnal symptoms are not reliable indicators of the presence of BE.

Entities:  

Mesh:

Year:  2001        PMID: 11588545     DOI: 10.1097/00004836-200110000-00010

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  41 in total

Review 1.  Screening and surveillance of Barrett's esophagus.

Authors:  Jeff Michalak; Ajay Bansal; Prateek Sharma
Journal:  Curr Gastroenterol Rep       Date:  2009-06

Review 2.  American Gastroenterological Association technical review on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

3.  Risk factors associated with Barrett's epithelial dysplasia.

Authors:  Mikiko Fujita; Yuri Nakamura; Saeko Kasashima; Maiko Furukawa; Ryoichi Misaka; Hikaru Nagahara
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

4.  Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach.

Authors:  Avi Rosenfeld; David G Graham; Sarah Jevons; Jose Ariza; Daryl Hagan; Ash Wilson; Samuel J Lovat; Sarmed S Sami; Omer F Ahmad; Marco Novelli; Manuel Rodriguez Justo; Alison Winstanley; Eliyahu M Heifetz; Mordehy Ben-Zecharia; Uria Noiman; Rebecca C Fitzgerald; Peter Sasieni; Laurence B Lovat
Journal:  Lancet Digit Health       Date:  2019-12-05

5.  Racial Disparity in the Sex Distribution, the Prevalence, and the Incidence of Dysplasia in Barrett's Esophagus.

Authors:  Prashanthi N Thota; Shamiq Zackria; Madhusudhan R Sanaka; Deepa Patil; John Goldblum; Rocio Lopez; Amitabh Chak
Journal:  J Clin Gastroenterol       Date:  2017 May/Jun       Impact factor: 3.062

6.  Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.

Authors:  Michael B Cook; Nicholas J Shaheen; Lesley A Anderson; Carol Giffen; Wong-Ho Chow; Thomas L Vaughan; David C Whiteman; Douglas A Corley
Journal:  Gastroenterology       Date:  2012-01-11       Impact factor: 22.682

Review 7.  Screening and Preventive Strategies in Esophagogastric Cancer.

Authors:  Liam Zakko; Lori Lutzke; Kenneth K Wang
Journal:  Surg Oncol Clin N Am       Date:  2017-04       Impact factor: 3.495

8.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Screening for Barrett's esophagus: results from a population-based survey.

Authors:  Milli Gupta; Timothy J Beebe; Kelly T Dunagan; Cathy D Schleck; Alan R Zinsmeister; Nicholas J Talley; G Richard Locke; Prasad G Iyer
Journal:  Dig Dis Sci       Date:  2014-03-21       Impact factor: 3.199

10.  Barrett's esophagus: where do we stand?

Authors:  Majid A Al Madi
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.